¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cross bridge cycle"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cross section radiography
    ´ÜÃþ¹æ»ç¼±ÃÔ¿µ(¼ú)
  • cross sensitivity
    ±³Â÷¹Î°¨µµ
  • cross sensitization
    ±³Â÷¹Î°¨È­
  • cross striation
    °¡·Î¹«´Ì, Ⱦ¹®
  • cross training
    ±³Â÷ÈÆ·Ã
  • cross-antigenicity
    ±³Â÷Ç׿ø¼º
  • cross-contamination
    ±³Â÷¿À¿°
  • cross-cultural psychiatry
    ¹®È­ºñ±³Á¤½ÅÀÇÇÐ
  • cross-dressing
    ÀÇ»óµµÂøÁõ
  • cross-face
    ±³Â÷¾ó±¼
  • cross-finger
    ±³Â÷¼Õ°¡¶ô
  • cross-finger flap
    ±³Â÷¼Õ°¡¶ôÇÇÆÇ
  • cross-finger technique
    ¼Õ°¡¶ô±³Â÷¹ý, ¼öÁö±³Â÷¹ý
  • cross-leg
    ±³Â÷Á¾¾Æ¸®
  • cross-leg flap
    ±³Â÷Á¾¾Æ¸®ÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cross-tolerance
    ±³Â÷³»¼º
  • cross-validation
    ±³Â÷Ÿ´çµµ
  • criss-cross inheritance
    ½ÊÀÚÀ¯Àü, À̼ºÀ¯Àü
  • cross circulation
    ±³Â÷¼øÈ¯
  • cross cylinder
    ±³Â÷¿øÁÖ·»Áî
  • cross examination
    ±³Â÷°Ë»ç
  • cross fertilization
    ±³Â÷¼öÁ¤, Ÿ°¡¼öÁ¤
  • cross fixation
    ±³Â÷ÁÖ½Ã
  • cross foot
    ¾ÈÂʹøÁü¹ß, ³»¹øÁ·
  • cross heredity
    ±³Â÷À¯Àü
  • cross immunity
    ±³Â÷¸é¿ª
  • cross incision
    ½ÊÀÚÀý°³
  • cross infection
    ±³Â÷°¨¿°
  • cross inheritance
    ±³Â÷À¯Àü
  • cross matching
    ±³Â÷½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • genesial cycle
    ¿©ÀÚ»ý½ÄÁÖ±â.
  • glucose lactate cycle
    ±Û·çÄÚ¿À½º¶ôÆ®»ê ȸ·Î.
  • gravitational cycle
    ÀÓ½ÅÁÖ±â
  • growth cycle
    Áõ½ÄÁÖ±â
  • hair cycle
    ¸ð¹ßÁÖ±â(Ù¾ ñÎÑ¢)
  • hydrogen cycle
    ¼ö¼Òȯ(¡­ü»), ¼ö¼Ò°í¸®.
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • intranuclear cycle
    ÇÙ³»»ýȰȯ.
  • life cycle
    »ýȰÁÖ±â
  • life cycle
    »ýȰÁÖ±â(~ñÎÑ¢)
  • life cycle
    »ýȰ»ç, »ýȰÁÖ±â, »ýȰȯ
  • male reproductive cycle
    ³²¼º»ý½ÄÁÖ±â
  • mammary cycle
    Á¥»ùÁÖ±â
  • menstrual cycle
    ¿ù°æÁÖ±â.
  • menstrual cycle
    ¿ù°æÁÖ±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • pentose cycle
    "ÆæÅ佺(¿Àź´ç, çé÷©ÓØ) ȸ·Î(üÞÖØ)"
  • pentose oxidation cycle
    "ÆæÅ佺(¿Àź´ç,çé÷©ÓØ) »êÈ­ ȸ·Î(ß«ûùüÞÖØ)"
  • phosphatidylinositol cycle
    Æ÷½ºÆÄƼµôÀ̳ë½ÃÅç ȸ·Î(üÞÖØ)
  • photosynthesis cycle
    ±¤ÇÕ¼º ȸ·Î(ÎÃùêà÷üÞÖØ)
  • photosynthetic cycle
    ±¤ÇÕ¼º ȸ·Î(üÞÖØ)
  • PI cycle
    PI(Phosphatidylinositol) ȸ·Î(üÞÖØ)
  • purine cycle
    Ǫ¸° ȸ·Î(üÞÖØ)
  • purine nucleotide cycle
    Ç»¸° ´©Å¬·¹¿ÀŸÀ̵å ȸ·Î(üÞÖØ)
  • putrescine cycle
    ǪƮ·¹½Å ȸ·Î(üÞÖØ)
  • pyridine nucleotide cycle
    ÇǸ®µò ´©Å¬·¹¿ÀŸÀ̵å ȸ·Î(üÞÖØ)
  • Q cycle
    Q ȸ·Î(üÞÖØ)
  • quinone cycle
    Äû³í ȸ·Î(üÞÖØ).
  • reductive carboxylic acid cycle
    ȯ¿ø¼º(ü½êªàõ) Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ)
  • reductive pentose cycle
    ȯ¿ø¼º(ü½êªàõ) ÆæÅ佺 ȸ·Î(üÞÖØ)
  • reductive pentose phosphate cycle
    ȯ¿ø¼º(ü½êªàõ) Àλê(×òß«)ÆæÅ佺 ȸ·Î(üÞÖØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
UCE urea cycle enzymopathy
WCL Wenckebach cycle length; whole cell lysate
CREG Cross REactive Group (of HLA Antigens)
IRC International Red Cross
ANRC American National Red Cross
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CMM Cross-modality matching
CP Cross-polarization
CRM Cross-reacting material
CRI Cross-reactive idiotypes
X-SA Cross-sectional area
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cross-linkage
    ±³Â÷ °áÇÕ
  • cross-match
    ±³Â÷ ÀûÇÕ
  • cross-over position
    ¹Ý´ëÀ§
  • cross-reactivity
    ±³Â÷ ¹ÝÀÀ¼º
  • cross-section
    Ⱦ´Ü ¸é
    ¾î´À ½ÃÆíÀÇ ³»ºÎ¸¦ °üÂûÇϱâ À§ÇÏ¿© ÀϹÝÀûÀ¸·Î Á߽ɺθ¦ Ⱦ´Ü½ÃÄÑ °¡·Î ¶Ç´Â ¼¼·Î·Î ÀÚ¸¥ ¸é.
  • cross-sectional sample
    ȾÀûÀÎ °æ¿ì
  • cross-sectional study
    Ⱦ´Ü ¿¬±¸¹ý, Ⱦ´Ü Á¶»ç¹ý
  • posterior cross bite
    ±¸Ä¡ ¹Ý´ë±³ÇÕ, ±¸Ä¡ºÎ ¹Ý´ë±³ÇÕ
  • sagittal cross section
    ½Ã»ó´Ü
    ½Ã»ó¸é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
cell cycle restriction point <cell biology, molecular biology> A point, late in G1, after which the cell must, normally, proceed through to division at its standard rate.
(26 Mar 1998)
cell division cycle gene Genes which control the yeast cell cycle. There are around 50 different genes which do this.
(09 Oct 1997)
cell division cycle mutant A yeast cell which has cell division cycle genes that have mutated to become sensitive to temperature, at certain temperatures (usually high ones), various parts of the normal yeast cell cycle become abnormal, and in some strains the yeast cell does not survive at all.
(09 Oct 1997)
reproductive cycle The cycle which begins with conception and extends through gestation and parturition.
(05 Mar 2000)
glycine-succinate cycle A series of metabolic steps in which glycine is condensed with succinyl-CoA and is then oxidised to CO2 and H2O with regeneration of the succinyl-CoA; important in the synthesis of d-aminolevulinic acid and in the metabolism of red blood cells.
Synonym: Shemin cycle.
(05 Mar 2000)
restored cycle An atrial or ventricular cardiac cycle that follows the returning cycle and resumes the normal rhythm.
(05 Mar 2000)
glyoxylate cycle <biochemistry> Metabolic pathway present in bacteria and in the glyoxisome of plants, in which two acetyl CoA molecules are converted to a 4 carbon dicarboxylic acid, initially succinate.
Includes two enzymes not found elsewhere, isocitrate lyase and malate synthase. Permits net synthesis of carbohydrates from lipid and hence is prominent in those seeds in which lipid is the principal food reserve.
(18 Nov 1997)
glyoxylic acid cycle A catabolic cycle in plants and microorganisms like that of the tricarboxylic acid cycle in animals; its key reaction is the condensation of acetyl-CoA with glyoxylic acid to malic acid (analogous to the condensation of acetyl-CoA and oxaloacetic acid to form citric acid in the tricarboxylic acid cycle).
Synonym: Krebs-Kornberg cycle.
(05 Mar 2000)
pentose phosphate cycle <biochemistry> A pathway of hexose oxidation in which glucose-6-phosphate undergoes two successive oxidations by NADP, the final one being an oxidative decarboxylation to form a pentose phosphate.
Diverges from this when glucose-6-phosphate is oxidized to ribose 5 phosphate by the enzyme glucose-6 phosphate dehydrogenase. This step reduces NADP to NADPH, generating a source of reducing power in cells for use in reductive biosyntheses.
In plants, part of the pathway functions in the formation of hexoses from carbon dioxide in photosynthesis. Also important as source of pentoses, for example for nucleic acid biosynthesis. This pathway is the main metabolic pathway in neutrophils, congenital deficiency in the pathway produces sensitivity to infection.
Alternative metabolic route to Embden Meyerhof pathway for breakdown of glucose.
(18 Nov 1997)
gonadotrophic cycle One complete round of ovarian development in the insect vector from the time when the blood meal is taken to the time when the fully developed eggs are laid.
(05 Mar 2000)
returning cycle An atrial or ventricular cardiac cycle that begins with an extrasystole or a forced beat.
(05 Mar 2000)
menstrual cycle The reproductive cycle of female humans. The cycle is characterised by a monthly discharge of blood, mucus, and tissues from the uterus (called menstruation) and involves changes to the lining of the uterus (the endometrium) during the rest of the month including a few days of fertility after an ovum (egg) is released by an ovary.
(09 Oct 1997)
chewing cycle A complete course of movement of the mandible during a single masticatory stroke.
(05 Mar 2000)
Ross cycle The life cycle of the malaria parasite.
(05 Mar 2000)
citric acid cycle <biochemistry> The central feaure of oxidative metabolism. Cyclic reactions whereby acetyl CoA is oxidized to carbon dioxide providing reducing equivalents (NADH or FADH2) to power the electron transport chain. Also provides intermediates for biosynthetic processes.
(16 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • cross bun
    ½ÊÀÚ ¹«´Ì·Î ´çÀǸ¦ ÀÔÈù °úÀÚ »§
  • cross counter
    Å©·Î½ºÄ«¿îÅÍ(»ó´ë¹æ °ø°Ý¿¡ ´ëÇØ ±³Â÷ÀûÀ¸·Î °¡ÇÏ´Â ¹Ý°Ý)
  • cross current
    ¿ª·ù;´ë¸³ÇÏ´Â °æÇâ
  • cross cut
    °¡·Î ÄÑ´Â (Åé);°¡·Î ÀÚ¸¥;»û±æ;Áö¸§±æ;(Àç¸ñÀÇ)°¡·ÎÄѱâ;ȰÁÖÇüÀÇ ÀÏÁ¾(½ºÄÉÀÌÆ®);°¡·ÎÄÑ´Ù;°¡·ÎÁö¸£´Ù;~ter
  • cross fire
    ½ÊÀÚÆ÷È­;(Áú¹®ÀÇ)ÀÏÁ¦ °ø¼¼;(¸»ÀÇ)°Ý·ÄÇÑ ÀÀ¼ö;Ç÷¹ÀÌÆ®ÀÇ °¢À» ÁÇ·Î °¡·ÎÁö¸£´Â Åõ±¸
  • cross grain
    ¾ù°á
  • cross hairs
    (¸Á¿ø°æ µîÀÇ ÃÐÁ¡¿¡ »ý±ä)½ÊÀÚ¼±
  • cross keys
    2 °³ÀÇ ¿­¼è°¡ ±³Â÷ÇÑ ¹®Àå(·Î¸¶ ±³È²ÀÇ)
  • cross license
    »óÈ£ ƯÇã »ç¿ë Çã°¡
  • cross matching
    ±³Â÷(ÀûÇÕ)½ÃÇè
  • cross multiply
    µÎ ºÐ¼öÀÇ °¢°¢ÀÇ ºÐÀÚ¿¡ ´Ù¸¥ ºÐ¼öÀÇ ºÐ¸ð¸¦ °öÇÏ´Ù
  • cross rate
    Å©·Î½º ·¹ÀÌÆ®;¿µ.¹Ì ȯ½Ã¼¼
  • cross sea
    ³î;¿ªÇ³¶û
  • cross section
    °¡·ÎÀÚ¸£±â;Ⱦ´Ü¸é;´Ü¸éµµ;(»çȸ µîÀÇ)´ëÇ¥ÀûÀÎ ¸é;´Ü¸é
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á